Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 7849108, 14 pages
https://doi.org/10.1155/2017/7849108
Review Article

Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Correspondence should be addressed to Tiziana Triulzi; ti.im.iromutotutitsi@izluirt.anaizit

Received 25 August 2017; Accepted 21 November 2017; Published 18 December 2017

Academic Editor: Paul Span

Copyright © 2017 Martina Di Modica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Martina Di Modica, Elda Tagliabue, and Tiziana Triulzi, “Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host,” Disease Markers, vol. 2017, Article ID 7849108, 14 pages, 2017. doi:10.1155/2017/7849108